Madrigal Pharmaceuticals EVP and CFO Dier Mardi sells shares, buys others on December 2.
ByAinvest
Wednesday, Dec 3, 2025 6:06 pm ET1min read
MDGL--
Madrigal Pharmaceuticals Inc. (MDGL) has disclosed that EVP and CFO Dier Mardi engaged in various transactions involving the company's shares on December 2, 2025. Specifically, Mardi sold 717 shares at $574 per share, 120 shares at $574.95 per share, 320 shares at $577.81 per share, 80 shares at $596.19 per share, 258 shares at $578.83 per share, 354 shares at $573.02 per share, 160 shares at $589.65 per share, 240 shares at $585.44 per share, and 410 shares at $571.99 per share. In addition, Mardi purchased 4173 shares at $251.63 per share on the same day.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet